
|Articles|December 1, 2017
- Pharmaceutical Executive-12-01-2017
- Volume 37
- Issue 12
Pharmaceutical Executive, December 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Global Health: Fighting the Good Fightover 8 years ago
Global Health: Partnerships Hold the Keyover 8 years ago
First Foray into Digital Adherenceover 8 years ago
Global Health: Messages of Hopeover 8 years ago
A Year of Transformation for Science & Medicineover 8 years ago
Access and Reimbursement for Adoptive T-Cell Transfer Drugsover 8 years ago
Will Europe Turn a Corner in Personalized Medicine?over 8 years ago
Fulfilling the Vision of Science: AstraZeneca's Ruud Dobberover 8 years ago
Country Report: CanadaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Redefining Obesity Success in the GLP-1 Era: Q&A with Brian Hilberdink
2
FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010
3
Pharma Funding Roudup: Kardigan Announces $400 Million Initial IPO, cAMPfield Launches with $180 million Series A
4
Additive Manufacturing's Application in Pharma and Biotech
5




